Table: Genmont Biotech Mar Rev NT$38.3M Vs NT$43.8M

About this update from Genmont Biotech, Inc.

Genmont Biotech Inc. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$38,270,000 NT$43,777,000 Jan-Mar Revenue NT$89,170,000 NT$99,452,000 Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to [email protected].

View stock analysis, news, and events for Genmont Biotech, Inc.